Quantcast

Latest Sirolimus Stories

2011-08-30 12:28:35

Results of the independently-funded Bern-Rotterdam cohort study provide robust evidence of an "important" reduction in overall and very late stent thrombosis.

2011-08-29 20:19:10

A specific inhibitor of the small regulatory RNA-molecule “microRNA-100” can be used to stimulate the growth of new blood vessels, if a major artery is chronically occluded.

2011-07-29 14:38:29

For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications.

2011-07-26 12:10:00

DURHAM, N.C., July 26, 2011 /PRNewswire/ -- Micell Technologies, Inc. today announced that it has completed patient enrollment in its DESSOLVE II CE Mark clinical study of the MiStent® Drug-Eluting Coronary Stent System.

2011-07-18 10:46:00

HONG KONG, July 18, 2011 /PRNewswire/ -- Data from high-risk patients requiring early discontinuation of dual antiplatelet therapy (DAPT) due to nondeferrable, non-cardiac surgery show good short- and long-term clinical and safety outcomes following treatment with OrbusNeich's Genous Stent, according to a study published online on the journal Minerva Cardioangiologica's website. In the single-center study, patients treated with the Genous endothelial progenitor cell (EPC) capture stent...

2011-07-11 14:08:00

HONG KONG, July 11, 2011 /PRNewswire/ -- OrbusNeich today announced that data from an ex vivo arteriovenous (AV) shunt model of human circulating blood, in addition to results from three preclinical studies, demonstrated that the Genous Stent effectively captures circulating CD34+ endothelial progenitor cells (EPCs) leading to accelerated re-endothelialization and decreased thrombogenicity compared to bare metal stents (BMS).

2011-07-08 00:19:00

EAST HANOVER, N.J., July 8, 2011 /PRNewswire/ -- Novartis Pharmaceuticals Corporation ("Novartis") announced today Phase III trial results that showed more than one-third of patients taking Afinitor® (everolimus) tablets* experienced a 50% or greater reduction in the size of their subependymal giant cell astrocytomas (SEGAs), non-cancerous brain tumors associated with tuberous sclerosis complex (TSC)(1,2,6).


Word of the Day
gazingstock
  • A person or thing gazed at with wonder or curiosity, especially of a scornful kind.
The 'stock' of 'gazingstock' comes from an Old English word meaning 'tree trunk' or 'wood'.
Related